Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis
Cancers · 10.03.2026 · 18 (6) · 896
DOI: 10.3390/cancers18060896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 10.03.2026. Verfasst von Julia Wojnicka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin,…. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
Background
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and is characterized by dysregulated apoptosis and metabolic reprogramming, including alterations in lipid metabolism. However, the plasma lipidome of newly diagnosed, treatment-naïve CLL patients remains insufficiently characterized. This study aimed to define disease-specific plasma lipidomic alterations, identify discriminatory lipid species, and investigate associated metabolic pathways.
Methods
The study cohort consisted of 41 participants (median age 75 years, range: 40–86), including 30 newly diagnosed, treatment-naïve CLL patients (median age 75 years, range: 40–86) and 11 age- and sex-matched healthy controls (median age 75 years, range: 41–85). Targeted lipidomic profiling was performed on plasma samples using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Data processing was conducted in R using LipidSigR. Statistical analyses employed the Wilcoxon–Mann–Whitney test with Benjamini–Hochberg correction. To address data dimensionality, Boruta machine learning and pathway enrichment analyses were applied. Gene–lipid associations were further explored using GATOm, followed by Metascape analysis to identify enriched biological processes.
Results
A total of 124 lipid species from five major classes (phosphatidylcholines, lysophosphatidylcholines, sphingomyelins, ether-linked phosphatidylcholines, and acylcarnitines) were quantified. CLL patients exhibited significant enrichment of acylcarnitines, saturated phosphatidylcholines, and sphingolipids compared with controls. Principal component analysis showed partial separation by disease status. Machine learning identified carnitines and ether-linked phospholipids as key discriminators. Integrated gene–lipid analyses revealed significant enrichment of lipid metabolism-related pathways, particularly glycerolipid and phosphatidylcholine metabolism, as well as lipid catabolism, ether lipid metabolism, and fatty acid metabolism.
Conclusions
Treatment-naïve CLL patients display distinct plasma lipidomic signatures indicative of disease-specific metabolic reprogramming. Integrated lipidomic and predictive pathway analyses suggest disruptions in lipid metabolic pathways and highlight carnitines and ether-linked phospholipids as biological markers warranting further investigation as potential CLL biomarkers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin, Poland.
- Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin, Poland.
- Department of Experimental Immunology, Medical University of Lublin, 4a Chodźki St., 20-093 Lublin, Poland.
- Department of Bioanalytics, Medical University of Lublin, 8b Jaczewskiego St., 20-090 Lublin, Poland.
- Department of Oncocardiology, Holy Cross Cancer Center, 25-734 Kielce, Poland.
- Department of Pediatric Endocrinology and Diabetology, Medical University of Lublin, 1 Gębali St., 20-093 Lublin, Poland.
ORCID-Profile: Julia Wojnicka, Michał Kiełbus, Paulina Mertowska, Sebastian Mertowski, Ewelina Grywalska, Piotr Sosnowski, Barbara Sosnowska-Pasiarska, Anna Błażewicz
Förderung
- Medical University of Lublin
Zitieren
APA
Wojnicka, J., Kiełbus, M., Mertowska, P., Mertowski, S., Grywalska, E., Sosnowski, P., Wielgosz, A., Kozub-Pędrak, A., Sosnowska-Pasiarska, B., Klatka, M., Klatka, J., & Błażewicz, A. (2026). Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. Cancers, 18(6), 896. https://doi.org/10.3390/cancers18060896
Vancouver
Wojnicka J, Kiełbus M, Mertowska P, Mertowski S, Grywalska E, Sosnowski P, et al. Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. Cancers. 2026;18(6):896. doi:10.3390/cancers18060896
BibTeX
@article{Wojnicka2026,
author = {Wojnicka, Julia and Kiełbus, Michał and Mertowska, Paulina and Mertowski, Sebastian and Grywalska, Ewelina and Sosnowski, Piotr and Wielgosz, Alicja and Kozub-Pędrak, Anna and Sosnowska-Pasiarska, Barbara and Klatka, Maria and Klatka, Janusz and Błażewicz, Anna},
title = {Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis},
journal = {Cancers},
year = {2026},
volume = {18},
number = {6},
pages = {896},
doi = {10.3390/cancers18060896}
}
EUVIMED